Musculoskeletal Instructional Course:
Tracks
Risso 8
| Tuesday, November 5, 2019 |
| 4:20 PM - 5:50 PM |
| Risso 8 |
Overview
The Official Positions of the International Society for Clinical Densitometry: Indications for Bone Density Testing in Spinal Cord Injury
Speaker
Dr Leslie Morse
Chair And Professor
University Of Minnesota School Of Medicine
The Official Positions of the International Society for Clinical Densitometry: Indications for Bone Density Testing in Spinal Cord Injury
Abstract
Dr. Leslie Morse, DO (25 minutes) will review the results of a systematic review focused on indications for initial DXA, diagnosis of osteoporosis, and fracture risk prediction by DXA in SCI. She will present newly developed positions statements created by a task force and endorsed by the International Society for Clinical Densitometry.
Dr. Cathy Craven, MD (25 minutes) will review a protocol for determination of bone density by DXA at the distal femur and proximal tibia. She will present a newly developed calculator to determine T- and Z-scores at both regions that will be made publicly available.
Dr. Fin Biering-Soerensen, MD (25 minutes) will review the results of a systematic review focused on DXA to monitor response to therapy in SCI. He will present newly developed positions statements created by a task force and endorsed by the International Society for Clinical Densitometry.
Dr. Therese Johnston, PhD (25 minutes) will review the results of a systematic review focused on DXA based contraindications to weight-bearing therapies in SCI. She will present newly developed positions statements created by a task force and endorsed by the International Society for Clinical Densitometry.
15 minutes: Speakers will facilitate an audience discussion focused on implementation of these position statements into clinical practice and research protocols.
Dr. Cathy Craven, MD (25 minutes) will review a protocol for determination of bone density by DXA at the distal femur and proximal tibia. She will present a newly developed calculator to determine T- and Z-scores at both regions that will be made publicly available.
Dr. Fin Biering-Soerensen, MD (25 minutes) will review the results of a systematic review focused on DXA to monitor response to therapy in SCI. He will present newly developed positions statements created by a task force and endorsed by the International Society for Clinical Densitometry.
Dr. Therese Johnston, PhD (25 minutes) will review the results of a systematic review focused on DXA based contraindications to weight-bearing therapies in SCI. She will present newly developed positions statements created by a task force and endorsed by the International Society for Clinical Densitometry.
15 minutes: Speakers will facilitate an audience discussion focused on implementation of these position statements into clinical practice and research protocols.
Biography
Dr. Leslie Morse, DO, is Chair and Professor, Department of Rehabilitation Medicine, University of Minnesota School of Medicine. Her research, as well as her clinical focus, is the care of individuals with SCI, with a long-term goal of developing mechanism-based therapies to prevent and treat SCI-induced osteoporosis. To that end, she is studying the impact of exoskeleton-assisted ambulation on bone health after SCI (a clinical trial supported by the Department of Defense); and the mechanisms of rapid-onset, SCI-related osteoporosis. She also studies the neuro-regenerative potential of dental pulp stem cells. Dr. Morse completed her medical training at the University of New England and her residency in PM&R at Boston Medical Center. Author of more than 70 publications, she has received several national best-paper awards and presented her work nationally and internationally.
Research interests: spinal cord injury and osteoporosis, therapies for bone health in SCI, affect of FES-rowing on bone and cardiac health in SCI, markers of bone health in SCI.
